Showing results (451-460 of 488) with videos related to

Sort By:
Pageof 49
Mbio|March 10, 2021
Queuine Is a Nutritional Regulator of Entamoeba histolytica Response to Oxidative Stress and a Virulence AttenuatorShruti Nagaraja, Maggi W Cai, Jingjing Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2022
Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS)A Zer, O Icht, L Yosef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced MelanomaCaroline Robert, Matteo S Carlino, Catriona McNeil, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Nature Neuroscience|June 19, 2023
Multicellular communities are perturbed in the aging human brain and Alzheimer's diseaseAnael Cain, Mariko Taga, Cristin McCabe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2024
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 studyG V Long, M S Carlino, C McNeil, et al.
Nucleic Acids Research|July 17, 2018
Integrating Rio1 activities discloses its nutrient-activated network in Saccharomyces cerevisiaeMaria G Iacovella, Michael Bremang, Omer Basha, et al.
Lancet (London, England)|August 21, 2017
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)Jacob Schachter, Antoni Ribas, Georgina V Long, et al.
The European Journal of Neuroscience|March 5, 2025
Is the Subthalamic Nucleus Sleeping Under Nitrous Oxide-Ketamine General Anesthesia?Halen Baker Erdman, Hagai Bergman, Karin Abu Haya, et al.
Journal of Immunology Research|June 14, 2016
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 BlockadeMichal Lotem, Sharon Merims, Stephen Frank, et al.
Pageof 49